Physician profile
Matthew Simhon
NPI 1396372157
$53,987.35
in general payments reported to CMS, 2019-2025
6 companies · $52K in 2025
The $52K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $949 · 2024: $1,274 · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $3,600 · Travel and Lodging: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $3,599.62 |
| Travel and Lodging | $387.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52,475.93 | 2023-2025 | Cd Horizon Spinal System, Mazor X System, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Stryker Corporation | $898.33 | 2024-2025 | Everest Spinal System, T2 Alpha, Gamma |
| Zimmer Biomet Holdings, INC. | $195.80 | 2023 | Persona |
| Depuy Synthes Sales INC. | $145.07 | 2025 | Va-Lcp |
| Axogen | $139.66 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Linvatec Corporation | $132.56 | 2025 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Simhon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.